ARTICLE | Company News
Novimmune, Tiziana deal
January 6, 2017 9:34 PM UTC
Novimmune granted Tiziana exclusive, worldwide rights to develop and commercialize NI-1201. Tiziana said it considers the compound a candidate to treat autoimmune inflammatory disease and will initial...
BCIQ Target Profiles